Lixinitide approved in the U.S. under the name Adlixin not Lyxumia

Page Changed: GLP-1 Agonists

Changed references to Lyxumia to "Adlixin" as that is the name that is being used for this dangerous, not particularly effective "me too" drug in the U.S. generic name lixisenatide, which was just approved by the rubber stamp FDA. It is not being trade named Lyxumia, which is its name in the rest of the world. The change suggests it hasn't been selling well or getting good reviews under the old trade name.